Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
Gupta, V
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. [electronic resource] - Bone marrow transplantation Mar 2005 - 467-71 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704799 doi
Adolescent
Adult
Alemtuzumab
Anemia, Aplastic--complications
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bone Marrow Transplantation--adverse effects
Child
Cyclophosphamide--administration & dosage
Graft Survival
Graft vs Host Disease--pathology
Histocompatibility Testing
Humans
Immunosuppression Therapy
Incidence
Tissue Donors
Treatment Outcome
Vidarabine--administration & dosage
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. [electronic resource] - Bone marrow transplantation Mar 2005 - 467-71 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704799 doi
Adolescent
Adult
Alemtuzumab
Anemia, Aplastic--complications
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bone Marrow Transplantation--adverse effects
Child
Cyclophosphamide--administration & dosage
Graft Survival
Graft vs Host Disease--pathology
Histocompatibility Testing
Humans
Immunosuppression Therapy
Incidence
Tissue Donors
Treatment Outcome
Vidarabine--administration & dosage